Deka Biosciences - Crunchbase Company Profile & Funding

Q: Who invested in Deka Biosciences?

Deka Biosciences has 10 investors including MPM Capital And Echo Investment Capital.

Q: When was the last funding round for Deka Biosciences?

Deka Biosciences closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Deka Biosciences raised to date?

Deka Biosciences has raised obfuscated.

Overview

Deka Biosciences

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Deka Biosciences

CB Rank

40296

Early stage biotechnology company

Founded

obfuscation

Private

Venture - Series Unknown

Germantown, Maryland, United States

11-50

www.dekabiosciences.com

Biotechnology

Health Care

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series B

OBF

obfuscation

Series B

OBF

obfuscation

Key People

John Mumm: Co-Founder, Chief Executive Officer
Past Role: MedImmune, Director
Pavel Khrimian: Co-Founder & CBO

Details

Legal Name

Deka Biosciences

Operating Status

Active

Company Type

For Profit

Founders

John Mumm, Pavel Khrimian

About the Company

Early stage biotechnology start-up developing next generation cytokine therapeutics

Phone Number

6502670338

Contact Email

mummj@dekabiosciences.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Diakine™ Platform

A cytokine therapy platform combining paired cytokines to treat cancer and inflammatory diseases by targeting affected tissues to modulate immune responses.

DK210 (EGFR)

A dual-cytokine therapy combining interleukin-2 and a high-affinity interleukin-10 targeted to tumors overexpressing EGFR to stimulate immune cells against cancer.

Research & Development

Deka Biosciences is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Deka Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Deka Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Deka Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Deka Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Deka Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Deka Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Deka Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Deka Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Deka Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Deka Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
MPM Capital	Yes	Series B - Deka Biosciences	Detlev Biniszkiewicz
MPM Capital	Yes	Series B - Deka Biosciences	Detlev Biniszkiewicz
MPM Capital	Yes	Series B - Deka Biosciences	Detlev Biniszkiewicz
MPM Capital	Yes	Series B - Deka Biosciences	Detlev Biniszkiewicz
MPM Capital	Yes	Series B - Deka Biosciences	Detlev Biniszkiewicz